Navigator vs Standard Needle Injection for Hip

Completed · Phase 2

Conditions studied: Hip Pain Etiology Unknown

In brief

The purpose of this randomized, parallel-group, single-blinded, single center, Phase II study is to collect data to compare the comfort and patient satisfaction of a hip injection delivered via the Navigator compared to a standard needle injection. In addition, delivery preparation will be compared between a Navigator injection and a standard hip injection. The data collected from this pilot study will serve as the basis to design a larger multi-center study.

Key facts

Study ID
NCT02066844
Run by
Cartiva, Inc.
People needed
40
Starts
2014-02-01
Expected to finish
2014-08-01
Last updated by the study team
2016-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.